Clinical utility of circulating TWEAK and CD163 as biomarkers of iron-induced cardiac decompensation in transfusion dependent thalassemia major

CONCLUSION: Circulating TWEAK and CD163 appears to be promising biomarkers for monitoring MIO and predicting IICD in TDTM patients.PMID:38000169 | DOI:10.1016/j.cyto.2023.156443

Source: Cytokine - November 24, 2023 Category: Molecular Biology Authors: Mona M Watany Marwa M Elhosary Source Type: research